索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]吕志慧 常小倩 薛万腾 宋延彬 李小龙.脂联素在冠状动脉粥样硬化性心脏病及其危险因素中的研究进展[J].国际心血管病杂志,2020,01:5-8.
点击复制

脂联素在冠状动脉粥样硬化性心脏病及其危险因素中的研究进展(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2020年01期
页码:
5-8
栏目:
综述
出版日期:
2020-01-14

文章信息/Info

Title:
-
作者:
吕志慧 常小倩 薛万腾 宋延彬 李小龙
716000延安大学附属医院(吕志慧,常小倩,薛万腾,宋延彬); 716000延安大学附属医院神经外科(李小龙)
Author(s):
-
关键词:
脂肪因子;  脂联素;  冠状动脉粥样硬化性心脏病
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2020.01.002
文献标识码:
-
摘要:
脂联素是由脂肪细胞分泌的一种激素,具有增强胰岛素敏感性、改善葡萄糖代谢等多种生理作用。脂联素与冠状动脉粥样硬化性心脏病、肥胖、糖尿病、高血压、心肌缺血再灌注损伤等密切相关,该文介绍脂联素在冠状动脉粥样硬化性心脏病及其危险因素中的作用。
Abstract:
-

参考文献/References

[ 1 ]Esmaeili S, Motamedrad M, Hemmati M, et al. Prevention of kidney cell damage in hyperglycaemia condition by adiponectin[J]. Cell Biochem Funct, 2019, 37(3):148-152.
[ 2 ]Tan J, Tong A, Xu Y. Pancreatic β-cell function is inhibited by miR-3666 in type 2 diabetes mellitus by targeting adiponectin[J]. Braz J Med Biol Res, 2019, 52(6):e8344.
[ 3 ]Woodward L, Akoumianakis I, Antoniades C. Unravelling the adiponectin paradox: novel roles of adiponectin in the regulation of cardiovascular disease[J]. Br J Pharmacol, 2017, 174(22):4007-4020.
[ 4 ]Kim Y, Park CW. Mechanisms of adiponectin action: implication of adiponectin receptor agonism in diabetic kidney disease[J]. Int J Mol Sci, 2019, 20(7):E1782.
[ 5 ]Tao C, Sifuentes A, Holland WL. Regulation of glucose and lipid homeostasis by adiponectin: effects on hepatocytes, pancreatic β cells and adipocytes[J]. Best Pract Res Clin Endocrinol Metab, 2014, 28(1):43-58.
[ 6 ]Vasiliauskaité-Brooks I, Sounier R, Rochaix P, et al. Structural insights into adiponectin receptors suggest ceramidase activity[J]. Nature, 2017, 544(7648):120-123.
[ 7 ]Esmaili S, Xu A, George J. The multifaceted and controversial immunometabolic actions of adiponectin[J]. Trends Endocrinol Metab, 2014, 25(9):444-451.
[ 8 ]Ohman-Hanson RA, Cree-Green M, Kelsey MM, et al. Ethnic and sex differences in adiponectin: from childhood to adulthood[J]. J Clin Endocrinol Metab, 2016, 101(12):4808-4815.
[ 9 ]Ebrahimi-Mamaeghani M, Mohammadi S, Arefhosseini SR, et al. Adiponectin as a potential biomarker of vascular disease[J]. Vasc Health Risk Manag, 2015, 11:55-70.
[10]Margaritis M, Antonopoulos AS, Digby J, et al. Interactions between vascular wall and perivascular adipose tissue reveal novel roles for adiponectin in the regulation of endothelial nitric oxide synthase function in human vessels[J]. Circulation, 2013, 127(22):2209-2221.
[11]Sente T, Gevaert A, Van Berendoncks A, et al. The evolving role of adiponectin as an additive biomarker in HFrEF[J]. Heart Fail Rev, 2016, 21(6):753-769.
[12]Parida S, Siddharth S, Sharma D. Adiponectin, obesity, and cancer: clash of the bigwigs in health and disease[J]. Int J Mol Sci, 2019, 20(10):E2519.
[13]Qiao L, Wattez JS, Lee S, et al. Adiponectin deficiency impairs maternal metabolic adaptation to pregnancy in mice[J]. Diabetes, 2017, 66(5):1126-1135.
[14]Britton KA, Massaro JM, Murabito JM, et al. Body fat distribution, incident cardiovascular disease, cancer, and all-cause mortalit[J]. J Am Coll Cardiol, 2013, 62(10):921-925.
[15]Ruan H, Dong LQ. Adiponectin signaling and function in insulin target tissues[J]. J Mol Cell Biol, 2016, 8(2):101-109.
[16]Yan W, Zhang H, Liu P, et al. Impaired mitochondrial biogenesis due to dysfunctional adiponectin-AMPK-PGC-1α signaling contributing to increased vulnerability in diabetic heart[J]. Basic Res Cardiol, 2013, 108(3):329.
[17]Sun Y, Zhao D, Yang Y, et al. Adiponectin exerts cardioprotection against ischemia/reperfusion injury partially via calreticulin mediated anti-apoptotic and anti-oxidative actions[J]. Apoptosis, 2017, 22(1):108-117.
[18]赵林静, 崔柳苏, 张金盈, 等. 脂联素后处理对大鼠心肌缺血/再灌注损伤的影响及ADP/PI3K/Akt信号通路的作用[J]. 中国应用生理学杂志, 2017, 33(4):308-313.
[19]Essick EE, Ouchi N, Wilson RM, et al. Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling[J]. Am J Physiol Heart Circ Physiol, 2011, 301(3):H984-H993.
[20]Kajikawa M, Maruhashi T, Matsumoto T, et al. Relationship between serum triglyceride levels and endothelial function in a large community-based study[J]. Atherosclerosis, 2016, 249:70-75.
[21]Sasso FC, Pafundi PC, Marfella R, et al. Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study[J]. Cardiovasc Diabetol, 2019, 18(1):24.
[22]Ebrahimi-Mamaeghani M, Mohammadi S, Arefhosseini SR, et al. Adiponectin as a potential biomarker of vascular disease[J]. Vasc Health Risk Manag, 2015, 11:55-70.
[23]Wang Z, Wu Y, Zhang S, et al. The role of NO-cGMP pathway inhibition in vascular endothelial-dependent smooth muscle relaxation disorder of AT1-AA positive rats: protective effects of adiponectin[J]. Nitric Oxide, 2019, 87:10-22.
[24]Rojas E, Rodríguez-Molina D, Bolli P, et al. The role of adiponectin in endothelial dysfunction and hypertension[J]. Curr Hypertens Rep, 2014, 16(8):463.
[25]Yanai H, Yoshida H. Beneficial Effects of Adiponectin on glucose and lipid metabolism and atherosclerotic progression: mechanisms and perspectives[J]. Int J Mol Sci, 2019, 20(5):E1190.

备注/Memo

备注/Memo:
基金项目:国家自然科学基金(81760069); 陕西省重点研发计划(2018SF-116); 延安医疗卫生攻关项目(2018KS-16)
作者单位:716000延安大学附属医院(吕志慧,常小倩,薛万腾,宋延彬); 716000延安大学附属医院神经外科(李小龙)
通信作者:李小龙,E-mail:lixiaolongydfy@163.com
更新日期/Last Update: 2020-01-15